Danielle Naftulin

Partner
dnaftulin@cooley.com
Full contact info

It’s the coming together of best-in-class skills and get-it-done attitude that really sets Cooley apart. We know what’s worth fighting for.

About Danielle

Danielle represents emerging companies and venture capital investors in the formation and financing of high-growth life sciences/healthcare and technology companies. She has nearly 25 years of experience counseling emerging companies and their venture investors on a range of issues and transactions, including formation, venture capital financing, mergers and acquisitions, recapitalizations, spinouts, and general corporate matters, as well as representing companies in initial public offerings and various other public financing and strategic transactions.

View full bio

Passions

Family

Giving back

Experience

Boostr Closes $7 Million Series A

Boostr Closes $7 Million Series A

Cooley advised Boostr on its $7 million Series A financing. Partner Danielle Naftulin led the Cooley team advising Boostr, a leading omni-channel CRM and order management platform designed for media and advertising companies.

Related contacts

Danielle Naftulin
Partner, Palo Alto

Related Practices & Industries

Emerging Companies
Venture Capital

Vivace Therapeutics Closes $30 Million Series C

Vivace Therapeutics Closes $30 Million Series C

Cooley advised Vivace Therapeutics on its $30 million Series C financing to fund clinical programs targeting the Hippo pathway. Partner Danielle Naftulin led the Cooley team advising Vivace Therapeutics, a small molecule drug discovery and development company.

Related contacts

Danielle Naftulin
Partner, Palo Alto

Related Practices & Industries

Emerging Companies
Venture Capital

Hinge Bio Closes $19 Million Series A

Hinge Bio Closes $19 Million Series A

Cooley advised Hinge Bio on its $19 million Series A financing. Partner Danielle Naftulin led the Cooley team advising Hinge Bio, a biotechnology company developing the next generation of multi-functional antibodies and Fc-fusion proteins that bind targets with multi-handed cooperativity.

Related contacts

Danielle Naftulin
Partner, Palo Alto

Related Practices & Industries

Emerging Companies
Venture Capital

Quizizz Closes $12.5 Million Series A

Quizizz Closes $12.5 Million Series A

Cooley advised Quizizz on its $12.5 million Series A financing to expand its product offering. Danielle Naftulin led the Cooley team advising Quizizz , an India-based edtech engagement platform used in more than 65% of US schools and 100+ countries around the world.

Related contacts

Danielle Naftulin
Partner, Palo Alto

Related Practices & Industries

Emerging Companies
Venture Capital

Truepill Closes $100 Million Series B and Series C Financings

Truepill Closes $100 Million Series B and Series C Financings

Cooley advised Truepill on its $100 million combined Series B and Series C financings. Partner Danielle Naftulin led the Cooley team advising Truepill, a telehealth platform for exceptional patient experiences.

Related contacts

Danielle Naftulin
Partner, Palo Alto
Noel Ripberger-Scheick
Associate, Palo Alto

Related Practices & Industries

Emerging Companies
Venture Capital
View more

Admissions and credentials

California

Rankings and accolades

Chambers USA: Venture Capital – California (2023, 2024)

Lawdragon: 500 Leading Dealmakers in America (2021, 2022, 2024, 2025)

YWCA of Silicon Valley: Tribute to Women in Industry

Northern California Super Lawyers: Rising Star

Danielle has been immensely valuable not only helping my new startup with normal startup issues but providing strategic advice. She knows the ins and outs of issues tech companies face from all angles. I'd recommend her to anyone starting a company or not getting the legal strategy they need.

Patrick O’Leary, Founder and CEO of Boostr